BIO applauds U.S. House passage of the American Research and Competitiveness Act (H.R. 4438), which would establish a permanent research tax credit. According to BIO President and CEO Jim Greenwood, the R&D tax credit is a vitally important incentive that spurs private-sector funding of the search for new cures and treatments for patients in need. This research not only produces new groundbreaking medical discoveries, but also supports millions of well-paying American jobs.
This story is related to the following:Trade Associations